Vivimed Labs OKs issue of $75 million foreign currency convertibles

By Jennifer Chiou

New York, Dec. 4 - Vivimed Labs Ltd. informed the Bombay Stock Exchange that its board voted to approve an issue of $75 million of foreign currency convertible bonds.

The meeting took place on Saturday.

The company noted that it may issue American Depositary Receipts or Global Depositary Receipts as alternatives.

The Hyderabad, India, company said shareholders already consented to the offering at a June 12 meeting.

Vivimed produces products that focus on oral care, sun care and hair care.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.